Levetiracetam D6 (pyrrolidin-D6)
| Product Name | Levetiracetam D6 (pyrrolidin-D6) |
|---|---|
| Alternate Names | Levetiracetam Stable Isotopes, Stable Isotopes of Levetiracetam |
| CAT No. | CS-O-02821 |
| CAS No. | 1133229-30-7 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 176.25 g/mol |
| Mol. For. | C₈H₈D₆N₂O₂ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Levetiracetam |
| Purity | 95% |
| Canonical Smiles | CCC(C(=O)N)N1CCCC1=O |
| InchIKey | HPHUVLMMVZITSG-QXMLZOKMSA-N |
| Inchl | InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1/i3D2,4D2,5D2 |
| IUPAC | (2S)-2-(2,2,3,3,4,4-hexadeuterio-5-oxopyrrolidin-1-yl)butanamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Levetiracetam D6, also known as pyrrolidin-D6, is a powerful anticonvulsant drug used to treat seizures and epilepsy. It is the deuterated form of Levetiracetam, which is a popular antiepileptic medication that works by preventing the excessive activity of nerve cells in the brain, thereby reducing the risk of seizures.
The chemical formula of Levetiracetam D6 is C8H12D6NO2, and it is classified as a nootropic drug due to its cognitive enhancing properties. It is available in the form of tablets, oral solutions, and injections, and is typically administered orally.
The drug has a half-life of approximately 6-8 hours, and its effects can last for up to 24 hours. It is rapidly absorbed by the body, and its bioavailability is not affected by food intake. Levetiracetam D6 is metabolized in the liver and excreted primarily through the kidneys.
The use of Levetiracetam D6 has been found to be safe and effective in reducing the frequency and severity of seizures in patients with epilepsy. It has also been found to improve cognitive function and memory in patients with Alzheimer's disease and dementia.
However, like all drugs, Levetiracetam D6 has potential side effects, including dizziness, drowsiness, and gastrointestinal disturbances. It is important to consult a doctor before using this medication and to follow the prescribed dosage carefully to avoid any adverse effects.
Get an Instant Quote
Related Compounds
rac-Levetiracetam-D₃ |